References
- Who are candidates for prevention and treatment for osteoporosis?Osteoporos Int19977116
- LippunerKGolderMGreinerREpidemiology and direct medical costs of osteoporotic fractures in men and women in SwitzerlandOsteoporos Int200516Suppl 2S8S1715378232
- CummingsSRMeltonLJEpidemiology and outcomes of osteoporotic fracturesLancet200235993191761176712049882
- ChrischillesEShiremanTWallaceRCosts and health effects of osteoporotic fracturesBone19941543773867917575
- ChapuyMCArlotMEDuboeufFVitamin D3 and calcium to prevent hip fractures in the elderly womenN Engl J Med199232723163716421331788
- SelhubJHomocysteine metabolismAnnu Rev Nutr19991921724610448523
- McLeanRRJacquesPFSelhubJHomocysteine as a predictive factor for hip fracture in older personsN Engl J Med2004350202042204915141042
- Van MeursJBDhonukshe-RuttenRAPluijmSMHomocysteine levels and the risk of osteoporotic fractureN Engl J Med2004350202033204115141041
- OzdemSSamanciSTasatargilAExperimental hyperhomocysteinemia disturbs bone metabolism in ratsScand J Clin Lab Invest200767774875617852810
- LentzSRErgerRADayalSFolate dependence of hyperhomocysteinemia and vascular dysfunction in cystathionine beta-synthase-deficient miceAm J Physiol Heart Circ Physiol20002793H97097510993757
- BanfiGIorioELCorsiMMOxidative stress, free radicals and bone remodelingClin Chem Lab Med200846111550155518847368
- Sanchez-RodriguezMARuiz-RamosMCorrea-MunozEMendoza-NunezVMOxidative stress as a risk factor for osteoporosis in elderly Mexicans as characterized by antioxidant enzymesBMC Musculoskelet Disord2007812418088440
- FlemingJTBaratiMTBeckDJBone blood flow and vascular reactivityCells Tissues Organs2001169327928411455124
- SteedMMTyagiNSenUSchuschkeDAJoshuaIGTyagiSCFunctional consequences of the collagen/elastin switch in vascular remodeling in hyperhomocysteinemic wild-type, eNOS−/−, and iNOS−/− miceAm J Physiol Lung Cell Mol Physiol20102993L30131120581102
- SenUTyagiNKumarMMoshalKSRodriguezWETyagiSCCystathionine-beta-synthase gene transfer and 3-deazaadenosine ameliorate inflammatory response in endothelial cellsAm J Physiol Cell Physiol20072936C1779178717855772
- TayamaJMunakataMYoshinagaKToyotaTHigher plasma homocysteine concentration is associated with more advanced systemic arterial stiffness and greater blood pressure response to stress in hypertensive patientsHypertens Res200629640340916940702
- KumarMTyagiNMoshalKSHomocysteine decreases blood flow to the brain due to vascular resistance in carotid arteryNeurochem Int20085368214219
- Bosch-MarceMPolaRWeckerABHyperhomocyst(e)inemia impairs angiogenesis in a murine model of limb ischemiaVasc Med2005101152215920995
- Riza ErbayATurhanHYasarASElevated level of plasma homocysteine in patients with slow coronary flowInt J Cardiol2005102341942316004886
- ManolagasSCCorticosteroids and fractures: a close encounter of the third cell kindJ Bone Miner Res20001561001100510841168
- FratzlPGuptaHSPaschalisEPRoschgerPStructure and mechanical quality of the collagen–mineral nano-composite in boneJ Mater Chem20041421152123
- McCreadieBRGoldsteinSABiomechanics of fracture: is bone mineral density sufficient to assess risk?J Bone Miner Res200015122305230811127195
- CarmelRLauKHBaylinkDJSaxenaSSingerFRCobalamin and osteoblast-specific proteinsN Engl J Med1988319270753260008
- IqbalMPAhmedMUmerMMehboobaliNQureshiAAEffect of methotrexate and folinic acid on skeletal growth in miceActa Paediatr200392121438144414971796
- McFarlaneSIMuniyappaRShinJJBahtiyarGSowersJROsteoporosis and cardiovascular disease: brittle bones and boned arteries, is there a link?Endocrine200423111015034190
- HerrmannMStangerOPaulweberBHufnaglCHerrmannWFolate supplementation does not affect biochemical markers of bone turnoverClin Lab20065234131136